S&T Bank Palatin Technologies Inc Call Options Transaction History

S&T Bank

  • $381 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About PALATIN TECHNOLOGIES INC

PTN Quotes by TradingView
  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $8.45M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track S&T Bank Portfolio

Follow S&T Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email